DOCSLIB.ORG

EOFF 2018 Agenda

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
EOFF 2018 Agenda UNDER THE PATRONAGE OF H.H. SHEIKH HAMDAN BIN RASHID AL MAKTOUM, DEPUTY RULER OF DUBAI, UAE MINISTER OF FINANCE, PRESIDENT OF DUBAI HEALTH AUTHORITY AGENDA 14th EMIRATES OBSTETRICS GYNECOLOGY & FERTILITY FORUM (EOFF) 2018 January 18th – 20th Roda Al Bustan Hotel Dubai, UAE www.eoff.ae 14th EMIRATES OBSTETRICS GYNECOLOGY 1 & FERTILITY FORUM (EOFF) 2018 32 CONTENTS MESSAGE FROM THE PRESIDENT 05 GENERAL INFORMATION 06 ABOUT DUBAI 07 CONFERENCE 08 SPEAKERS 11 FAMILY PLANNING WORKSHOP 24 IAN DONALD SCHOOL OF ULTRASOUND WORKSHOP 25 ALSO WORKSHOP 26 PARTNERS & SPONSORS 30 EXHIBITORS 31 14th EMIRATES OBSTETRICS GYNECOLOGY & FERTILITY FORUM (EOFF) 2018 4 14th EMIRATES OBSTETRICS GYNECOLOGY 32 & FERTILITY FORUM (EOFF) 2018 WELCOME Dear All, I am pleased to announce that under the patronage of H.H. Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, UAE Minister of Finance, President of Dubai Health Authority, the 14th Emirates Obstetrics Gynecology & Fertility Forum (EOFF) will take place on January 18th - 20th, 2018 at Roda Al Bustan Hotel Dubai, United Arab Emirates. The EOFF is a dedicated event for the gynecology and aims to offer professionals in the field a multidisciplinary platform to learn more about the women’s health, gynecological diseases, obstetrics and clinical research. The Exhibition will provide valuable opportunity to retailers and manufacturers within the industry in Dubai to share their products and technologies with worldwide manufactures and industry specialists. We cordially invite you to attend or to play a more active role by submitting your research and taking part in a workshop and forum. By attending the EOFF 2018 delegates will gain over 30 CME Accredited Hours. We look forward to welcoming you to EOFF 2018. President of EOFF Dr. Awatif Al Bahar 14th EMIRATES OBSTETRICS GYNECOLOGY 5 & FERTILITY FORUM (EOFF) 2018 32 EOFF AGENDA GENERAL INFORMATION The EOFF is a dedicated event for the gynecology and aims to offer professionals in the field a multidisciplinary platform to learn more about the women’s health, gynecological oncology, clinical research and discovery. EOFF 2018 Exhibition will provide valuable opportunity to retailers and manufacturers within the industry in Dubai to share their products and technologies with worldwide manufactures and industry specialists. During EOFF 2018, we cordially invite you to attend the EOFF 2018 and play a more active role by submitting your research and taking part in a workshop and forum. REGISTRATION AND INFORMATION Registration Desk will operate as follows: Thursday, 18th January 2018 08:00 - 09:00 NAME TAGS Participants are required to wear their name tags throughout the meeting in order to be admitted to the lecture halls and other scheduled activities. REFRESHMENT AND LUNCH Refreshment and Lunch will be offered in accordance with the breaks indicated on the timetable. CYBER INTERNET Free internet will be available in the exhibition area during the conference. “EOFF2018 ” MOBILE PHONES AND PHOTOGRAPHY Participants are kindly requested to keep their mobile phones silent in the session halls and refrain from taking photographs during sessions. CERTIFICATE OF ATTENDANCE Certificate of attendance will be available at the registration desk at the end of third day of the conference on Saturday, 20th January, 2018 at 18:45 6 14th EMIRATES OBSTETRICS GYNECOLOGY 32 & FERTILITY FORUM (EOFF) 2018 ABOUT DUBAI The Emirate of Dubai is the second largest of the seven United Arab Emirates but has the biggest population at over 2.1 million inhabitants. Size has been synonymous with Dubai as it continues to build the first, largest and the biggest constructions in the world. A NEWBIE TOURIST TO DUBAI CAN GET CONFUSED AS IT OFFERS AN EXCITING ABUNDANCE OF ATTRACTIONS, ACTIVITIES, SHOPPING. HERE’S A TOP LIST OF THINGS TO DO WHEN HOLIDAYING IN DUBAI. Dubai’s dynamics are always transient and ever- centres, nightlife and hotels. Although it changing with its constant urge to construct strictly safeguards its traditional practices, it something better and bigger than the previous. allows space for other religions to breathe, a If there was a Palm Island, Nakheel thought of rare quality amongst the conservative Arab the World Island. Burj Al Arab seemed too timid world. Thankfully, it has been successful in when Burj Khalifa cropped up, distancing itself shielding itself from extremism, much-needed to being a loner in the crowd. Dubai constantly for it to survive. Today, Dubai has emerged dwells in a suppressive competition with itself as a cosmopolitan metropolis that has grown trying to magnetize tourists to a dreamy world steadily to become a global city and a business of attractions and unheard of luxuries. The and cultural hub of the Middle East and the emirate›s scoring points lie in its entrepreneurial Arab Gulf region. abilities to create the inconceivable found in its tourist attractions, landmarks, shopping 14th EMIRATES OBSTETRICS GYNECOLOGY 7 & FERTILITY FORUM (EOFF) 2018 32 EOFF AGENDA CONFERENCE Day 1 First Session Thursday, 18 January 2018 Chairpersons: Dr. Mohamed Elkayoubi & Dr. Bassel Noah 08:00 - 09:00 REGISTRATION FACTS AND DOUBTS ON THE PRENATAL ASSESSMENT OF 09:00 – 09:30 COGNITIVE FUNCTION OF BRAIN Dr. Asim Korjak 09:30 – 10:00 THE EVER CHANGING ROLE OF FIRST TRIMESTER ULTRASOUND Dr. Badreldeen Ahmed TH 10:00 – 10:30 THE 5 DIMENSION Dr. Mohamed Momtaz 10:30 – 10:45 DISCUSSION AND COFFEE BREAK Second Session Chairpersons: Dr. Zakwan Khrait & Dr. Shameem 10:45 – 11:15 THE EFFECTS OF MENOPAUSAL ESTROGEN DEPLETION Dr. Marco Gambacciani 11:15 – 11:45 FEMALE SEXUAL DYSFUNCTION Dr. Faysal Al Kak 11:45 – 12:15 GENETIC SCREENING IN HEREDITARY BREAST OVARIAN SYNDROMES Dr. Vineet Datta 12:15 – 12:45 CAN WE POSTPONE MENOPAUSE? Dr. Marco Gambacciani 12:45 – 13:30 DISCUSSION AND LUNCH BREAK Day 1 Third Session Thursday, 18 January 2018 Chairpersons: Dr. Mazen Dayhe & Dr. Mohammed Eid 13:30 – 14:00 INDIVIDUALISATION OF OVARIAN STIMULATION, UPDATE ANNO 2017 Dr. Human Fatimi HOW TO MAXIMIZE PCO PATIENTS CHANCE TO HAVE A BABY? 14:00 – 14:30 Dr. Luciano Nardo - Merck Sponsor Lecture 14:30 – 14:45 DISCUSSION Day 1 Fourth Session Thursday, 18 January 2018 Chairpersons: Dr. Amelie Hofmann & Dr.Sarooj 14:45 – 15:15 PCOS IN ADOLESCENCE: FROM GENETICS TO CLINICS Dr. Faysal Al Kak 15:15 – 15:45 GENETIC ASPECTS IN PEDIATRIC AND ADOLESCENT GYNECOLOGY Dr. Ivonne Alexandra Bedei 15:45 – 16:00 DISCUSSION Day 1 Fifth Session Thursday, 18 January 2018 Chairpersons: Dr. Zakwan Khrait & Dr. Razan Kayali SURGICAL MANAGEMENT OF STRESS URINARY INCONTINENCE 16:00 – 16:30 AND ITS COMPLICATIONS Dr. Vatche Arakel Minassian 16:30 – 17:00 MULLARIAN ANOMALIES–ENDOSCOPIC MANAGEMENT Dr. Hafeez Rahman 17:00 – 17:15 DISCUSSION 8 14th EMIRATES OBSTETRICS GYNECOLOGY 32 & FERTILITY FORUM (EOFF) 2018 CONFERENCE Day 2 Sixth Session – Merck Serono Symposium Friday, 19 January 2018 Chairpersons: Dr. Awatif Albahar INDIVIDUAL LUTEOLYSIS AFTER GNRH-AGONIST TRIGGER FOR 09:00 – 09:30 FINAL OOCYTE MATURATION Dr. Human Fatimi 09:30 – 10:00 OPTIMIZING THE OOCYTES NUMBER IS THE KEY OF ART SUCCESS Dr. Sesh Sunkara 10:00 – 10:30 PROGESTERONE USAGE OPTIMIZATION ROAD MAP Dr. Luciano Nardo 10:30 – 10:45 DISCUSSION AND COFFEE BREAK Day 2 Seventh Session Friday, 19 January 2018 Chairpersons: Dr. Purnima Deb & Dr. Amala Nazareth 10:45 – 11:15 MISCARRIAGE: IS IT GENETICALLY DETERMINED? Dr. Hesham Arab 11:15 – 11:45 RECURRENT PREGNANCY LOSS A NEW CONCEPT Dr. Badreldeen Ahmed 11:45 – 12:15 IRON DEFICIENCY ANEMIA – VIFOR PHARMA SYMPOSIUM Dr. Hesham Arab 12:15 – 12:30 DISCUSSION 12:30 – 13:00 LUNCH BREAK AND PRAYERS Day 2 Eighth Session Friday, 19 January 2018 Chairpersons: Dr. Dalya Abu & Dr. Sarooj THE IMPORTANT ROLE OF GENETIC SCREENING (CARRIER 13:00 – 14:00 SCREENING AND NON-INVASIVE PRENATAL SCREENING) Dr. Luis Izquierdo IS MITOCHONDRIAL DNA QUANTITATION A POTENTIAL 14:00 – 14:30 BIOMARKER FOR EMBRYO VIABILITY? Dr. Ozge Uner Ayvaz 14:30 – 14:45 DISCUSSION Day 2 Ninth Session Friday, 19 January 2018 Chairpersons: Dr. Amelie Hofmann & Dr. Raja Hakki 14:45 – 15:15 FETAL SYNDROMES DETECTABLE BY DIFFERENT FORMS OF ULTRASOUND Dr. Asim Korjak 15:15 – 15:45 ABNORMALLY INVASIVE PLACENTA. THE OBSTETRICIAN NIGHTMARE Dr. Mohamed Momtaz 15:45 – 16:15 GENETICS OF TURNER SYNDROME Dr. Ivonne Alexandra Bedei 16:15 – 16:30 DISCUSSION Day 2 Tenth Session Friday, 19 January 2018 Chairpersons: Dr. Amala Nazareth & Dr. Wael Ismail MALE INVOLVEMENT AND WOMEN’S ACCESS TO ANTENATAL CARE (ANC) 16:30 – 17:00 Dr. Taha Umbeli SUCCESSFUL PREGNANCY OUTCOME FOLLOWING ABDOMENAL SACROHYSTEROPEXY 17:00 – 17:30 FOR THIRD DEGREE UTERINE PROLAPSE Dr. Ahmed Abdelkareem 17:30 – 17:45 DISCUSSION 14th EMIRATES OBSTETRICS GYNECOLOGY 9 & FERTILITY FORUM (EOFF) 2018 32 EOFF AGENDA CONFERENCE Day 3 Eleventh Session Saturday, 20 January 2018 Chairpersons: Dr. Gilbert & Dr. Hinaa Zaheer 09:00 – 09:30 WELCOME TO PREIMPLANTATION GENETIC TESTING, AND BYE BYE TO PGS Dr. Mohamed Aboulghar IS THERE A DIFFERENCE BETWEEN REAL LH & HCG IN OVARIAN STIMULATION? 09:30 – 10:00 Dr. Sesh Sunkara - Merck Sponsor Lecture 10:00 – 10:30 THE ADVANTAGES OF PREIMPLANTATION GENETIC SCREENING (PGS) Dr. Vereczkey Attila 10:30 – 10:45 DISCUSSION AND COFFEE BREAK Day 2 Twelfth Session Friday, 19 January 2018 Chairpersons: Dr. Josephine Jose & Dr. Nemet Abduljabbar 10:45 – 11:15 ROLE OF HORMONE THERAPY IN ENDOMETRIAL AND OVARIAN CANCER Dr. Amer Karam 11:15 – 11:45 NEW BIOMARKERS FOR THE EARLY DETECTION OF ENDOMETRIOSIS Dr. Michaela Jaksch 11:45 – 12:15 WORK UP OF UROGYN FOR A GENERAL GYN Dr. Vatche Arakel Minassian 12:15 – 12:30 DISCUSSION 12:30 – 13:30 LUNCH BREAK AND PRAYERS Day 2 Thirteenth Session Friday, 19 January 2018 Chairpersons: Dr. Ahmed Abdel Kreem & Dr. Nagham 13:30 – 14:00 ARE WE READY FOR POPULATION SCREENING OF INHERIT BREAST CANCER? Dr. Luis Izquierdo 14:00 – 14:30 SENTINEL LYMPH NODES IN ENDOMETRIAL AND CERVICAL CANCER Dr.
Load more

Recommended publications
  • The Male Reproductive System
    Management of Men’s Reproductive 3 Health Problems Men’s Reproductive Health Curriculum Management of Men’s Reproductive 3 Health Problems © 2003 EngenderHealth. All rights reserved. 440 Ninth Avenue New York, NY 10001 U.S.A. Telephone: 212-561-8000 Fax: 212-561-8067 e-mail: [email protected] www.engenderhealth.org This publication was made possible, in part, through support provided by the Office of Population, U.S. Agency for International Development (USAID), under the terms of cooperative agreement HRN-A-00-98-00042-00. The opinions expressed herein are those of the publisher and do not necessarily reflect the views of USAID. Cover design: Virginia Taddoni ISBN 1-885063-45-8 Printed in the United States of America. Printed on recycled paper. Library of Congress Cataloging-in-Publication Data Men’s reproductive health curriculum : management of men’s reproductive health problems. p. ; cm. Companion v. to: Introduction to men’s reproductive health services, and: Counseling and communicating with men. Includes bibliographical references. ISBN 1-885063-45-8 1. Andrology. 2. Human reproduction. 3. Generative organs, Male--Diseases--Treatment. I. EngenderHealth (Firm) II. Counseling and communicating with men. III. Title: Introduction to men’s reproductive health services. [DNLM: 1. Genital Diseases, Male. 2. Physical Examination--methods. 3. Reproductive Health Services. WJ 700 M5483 2003] QP253.M465 2003 616.6’5--dc22 2003063056 Contents Acknowledgments v Introduction vii 1 Disorders of the Male Reproductive System 1.1 The Male
    [Show full text]
  • Laparoscopic Organopexy with Non-Mesh Genital (LONG)
    www.nature.com/scientificreports OPEN Laparoscopic Organopexy with Non-mesh Genital (LONG) Suspension: A Novel Uterine Received: 14 November 2017 Accepted: 19 February 2018 Preservation Procedure for the Published: xx xx xxxx Treatment of Apical Prolapse Cheng-Yu Long1,2,3, Chiu-Lin Wang2,3, Chin-Ru Ker1, Yung-Shun Juan4, Eing-Mei Tsai1,3 & Kun-Ling Lin 1,3 To assess whether our novel uterus-sparing procedure- laparoscopic organopexy with non-mesh genital(LONG) suspension is an efective, safe, and timesaving surgery for the treatment of apical prolapse. Forty consecutive women with main uterine prolapse stage II or greater defned by the POP quantifcation(POP-Q) staging system were referred for LONG procedures at our hospitals. Clinical evaluations before and 6 months after surgery included pelvic examination, urodynamic study, and a personal interview to evaluate urinary and sexual symptoms with overactive bladder symptom score(OABSS), the short forms of Urogenital Distress Inventory(UDI-6) and Incontinence Impact Questionnaire(IIQ-7), and the Female Sexual Function Index(FSFI). After follow-up time of 12 to 30 months, anatomical cure rate was 85%(34/40), and the success rates for apical, anterior, and posterior vaginal prolapse were 95%(38/40), 85%(34/40), and 97.5%(39/40), respectively. Six recurrences of anterior vaginal wall all sufered from signifcant cystocele (stage3; Ba>+1) preoperatively. The average operative time was 73.1 ± 30.8 minutes. One bladder injury occurred and was recognized during surgery. The dyspareunia domain and total FSFI scores of the twelve sexually-active premenopausal women improved postoperatively in a signifcant manner (P < 0.05).
    [Show full text]
  • Chapter 14 – Female Reproductive Organs
    Chapter 14 – Female reproductive organs The fee allowance for a hysteroscopy procedure includes an amount for dilation and curettage (D&C) and the insertion of a Mirena coil so we will not reimburse additional fees charged for these procedures. Similarly, where a therapeutic hysteroscopy is carried out, we will not pay any additional fees charged for a diagnostic hysteroscopy. The fee allowance for a hysterectomy procedure for ovarian malignancy includes an amount for the removal of the omentum and so this should not be charged as an additional procedure. A cystoscopy should not be charged as an additional procedure alongside any suspension/uro-gynaecological procedure. The insertion of a suprapubic catheter is considered part and parcel of procedures such as a suprapubic sling or the retropubic suspension of the bladder neck and so we will not pay any additional fees charged for this procedure. The fee allowance for a colposcopy procedure includes an amount for a punch biopsy. The fee allowance for a therapeutic laparoscopy includes an amount for a diagnostic laparoscopy. The code for the insertion of a prosthesis into the ureter is intended for use by urologists inserting a stent and not for circumstances where the ureter is being identified during hysterectomy. However, we recognise this does involve some additional work and consider a small uplift in the fee to be reasonable. Many pathological processes result in the formation of adhesions so ‘adhesiolysis’ is considered to be a normal part and parcel of these procedures. Therefore, we do not have a specific code for the division of adhesions.
    [Show full text]
  • Sara Aghamohammadi, M.D
    Sara Aghamohammadi, M.D. Philosophy of Care It is a privilege to care for children and their families during the time of their critical illness. I strive to incorporate the science and art of medicine in my everyday practice such that each child and family receives the best medical care in a supportive and respectful environment. Having grown up in the San Joaquin Valley, I am honored to join UC Davis Children's Hospital's team and contribute to the well-being of our community's children. Clinical Interests Dr. Aghamohammadi has always had a passion for education, she enjoys teaching principles of medicine, pediatrics, and critical care to medical students, residents, and nurses alike. Her clinical interests include standardization of practice in the PICU through the use of protocols. Her team has successfully implemented a sedation and analgesia protocol in the PICU, and she helped develop the high-flow nasal cannula protocol for bronchiolitis. Additionally, she has been involved in the development of pediatric pain order sets and is part of a multi-disciplinary team to address acute and chronic pain in pediatric patients. Research/Academic Interests Dr. Aghamohammadi has been passionate about Physician Health and Well-being and heads the Wellness Committee for the Department of Pediatrics. Additionally, she is a part of the Department Wellness Champions for the UC Davis Health System and has given presentations on the importance of Physician Wellness. After completing training in Physician Health and Well-being, she now serves as a mentor for the Train-the-Trainer Physician Health and Well-being Fellowship.
    [Show full text]
  • Nutrition in Andrology, Gynaecology and Obstetrics
    Appendix No. 2 to the procedure of development and periodical review of syllabuses Nutrition in Andrology, Gynaecology and Obstetrics 1. Imprint Faculty name: English Division Syllabus (field of study, level and educational profile, form of studies, Medicine, 1st level studies, practical profile, full time e.g., Public Health, 1st level studies, practical profile, full time): Academic year: 2019/2020 Nutrition in Andrology, Gynaecology and Module/subject name: Obstetrics Subject code (from the Pensum system): Educational units: Department of Social Medicine and Public Health Head of the unit/s: Dr hab. n. med. Aneta Nitsch - Osuch Study year (the year during which the 1st-6th respective subject is taught): Study semester (the semester during which the respective subject is Winter and Summer semesters taught): Module/subject type (basic, corresponding to the field of study, Optional optional): Teachers (names and surnames and Anna Jagielska, MD degrees of all academic teachers of Aleksandra Kozłowska, BSc respective subjects): ERASMUS YES/NO (Is the subject available for students under the YES ERASMUS programme?): A person responsible for the syllabus (a person to which all comments to Anna Jagielska, MD the syllabus should be reported) Number of ECTS credits: 2 Page 1 of 4 Appendix No. 2 to the procedure of development and periodical review of syllabuses 2. Educational goals and aims The aim of the course is to provide students with: 1. The principles of nutrition during adolescence, adulthood and eldery. 2. The relationship between nutrition and fertility, fetal status and communicable diseases in the adults life. 3. Basics of dietary advices for men and women in the reproductive years.
    [Show full text]
  • To Repair Uterine Prolapse
    IP 372/2 [IPGXXX] NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapse Uterine prolapse happens when the womb (uterus) slips down from its usual position into the vagina. Uterine suspension using mesh involves attaching 1 end of the mesh to the lower part of the uterus or cervix. The other end is attached to a bone at the base of the spine or to a ligament in the pelvis. The procedure can be done through open abdominal surgery or laparoscopy (keyhole surgery). The aim is to support the womb. Introduction The National Institute for Health and Care Excellence (NICE) has prepared this interventional procedure (IP) overview to help members of the interventional procedures advisory committee (IPAC) make recommendations about the safety and efficacy of an interventional procedure. It is based on a rapid review of the medical literature and specialist opinion. It should not be regarded as a definitive assessment of the procedure. Date prepared This IP overview was prepared in January 2016. Procedure name Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapse. Specialist societies Royal College of Obstetricians and Gynaecologists (RCOG) British Society of Urogynaecology (BSUG) British Association of Urological Surgeons (BAUS). IP overview: Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapse. Page 1 of 75 IP 372/2 [IPGXXX] Description Indications and current treatment Uterine prolapse is when the uterus descends from its usual position, into and sometimes through, the vagina. It can affect quality of life by causing symptoms of pressure and discomfort, and by its effects on urinary, bowel and sexual function.
    [Show full text]
  • Andrology Program
    Andrology Program Overview of Fellowship Program Program Name: Male Reproductive Medicine and Surgery Program inception date: July 2017 Institution (s): University of Miami Andrology Fellowship Director: Ranjith Ramasamy, MD Summary of the Program: Clinical program: We see men with infertility, sexual dysfunction, penile abnormalities, scrotal/groin pain and/or testosterone deficiency syndrome. Our clinical team includes 3 sub-specialty urologists, and an andrology lab director. We collaborate closely with the REI and oncologists. In addition to clinical evaluation and operative training, fellows will gain experience in clinical andrology lab tests, management of infertility in men with spinal cord injury and exposure to a fertility preservation program. Research Program: We have a very active research program with basic science projects on human testis models to evaluate genetics of male infertility and clinical trial to evaluate the effect of clomiphene citrate on idiopathic male infertility. We also have dedicated laboratory space to study animal models with Klinefelter syndrome and Leydig stem cells. Fellowship Faculty: o Ranjith Ramasamy, MD o Charles Lynne, MD o Bruce Kava, MD o Nancy Brackett, PhD Number of Positions per Year: 1 Duration of Fellowship: 1 year fellowship: 80% clinical/20% research Accreditation: Jackson Health System Graduate Medical Education Andrology Program Who to contact regarding the program: Millie Ferro Urology Administration M-814 Leonard M. Miller School of Medicine Contact e-mail: [email protected] Contact phone number: (305) 243-3246 Fax: (305) 243-6597 Contact Website: Overview of Fellowship Program / Description of Program: The Male Reproductive Medicine and Surgery Fellowship will enable the fellow to acquire an advanced body of knowledge and level of skill in the management of reproductive and sexual health diseases in order to assume a leadership role in teaching and research in the field.
    [Show full text]
  • Abdominal Sacrohysteropexy Versus Vaginal Hysterectomy for Pelvic Organ Prolapse in Young Women
    International Journal of Reproduction, Contraception, Obstetrics and Gynecology Bhalerao AV et al. Int J Reprod Contracept Obstet Gynecol. 2020 Apr;9(4):1434-1441 www.ijrcog.org pISSN 2320-1770 | eISSN 2320-1789 DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20201201 Original Research Article Abdominal sacrohysteropexy versus vaginal hysterectomy for pelvic organ prolapse in young women Anuja V. Bhalerao, Vaidehi A. Duddalwar* Department of Obstetrics and Gynecology, N. K. P. Salve Institute of Medical Sciences, Nagpur, Maharashtra, India Received: 11 February 2020 Accepted: 03 March 2020 *Correspondence: Dr. Vaidehi A. Duddalwar, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Pelvic organ prolapse (POP) is the descent of the pelvic organs beyond their anatomical confines. The definitive treatment of symptomatic prolapse is surgery but its management in young is unique due to various considerations. Aim of this study was to evaluate anatomical and functional outcome after abdominal sacrohysteropexy and vaginal hysterectomy for pelvic organ prolapse in young women. Methods: A total 27 women less than 35 years of age with pelvic organ prolapse underwent either abdominal sacrohysteropexy or vaginal hysterectomy with repair. In all women, pre-op and post-op POP-Q was done for evaluation of anatomical defect and a validated questionnaire was given for subjective outcome. Results: Anatomical outcome was significant in both groups as per POP-Q grading but the symptomatic outcome was better for sacrohysteropexy with regard to surgical time, bleeding, ovarian conservation, urinary symptoms, sexual function.
    [Show full text]
  • Andrology Lab Booklet
    or Reprod er f uc nt ti e ve C M n a e c d i i r c e i Andrology Center and n m e A C e 3 9 n 9 tr 1 um t. E Es Reproductive Tissue Bank xcellentiae Who We Are What We Offer The Andrology Center and Reproductive Tissue Bank - The Andrology Center and Reproductive Tissue a section of the Glickman Urological & Kidney Institute Bank’s specialized laboratory offers a wide variety at Cleveland Clinic - provides specialized tests and of comprehensive tests and the latest technology services to evaluate male infertility. Our laboratory to meet patient needs. The Andrology Center offers offers referring physicians and patient’s quantifiable both research and clinical services. Our laboratory results using the latest state-of-the art technology. uses the latest World Health Organization (WHO, We are located in the Building X, which is part of the Fifth Edition, 2010) guidelines and reference ranges Downtown Main campus. in the evaluation of semen samples. Additionally, our laboratory’s Therapeutic Sperm Banking As part of the American Center for Reproductive program provides a complete fertility preservation Medicine, the Andrology Center and Reproductive service including a reliable system for the long-term Tissue Bank is staffed with highly qualified and preservation of human semen, epididymal aspirate experienced laboratory technologists who are well and testicular tissue. trained in fertility testing and certified by the American Society of Clinical Pathologists (ASCP). Our laboratory is certified by the Clinical Laboratory Improvement Table of Contents Amendments (CLIA) and the Department of Health and Human Services.
    [Show full text]
  • Ejaculation Problems3 9
    1 6 Fact Sheet 7 12 2 8 11 Ejaculation Problems3 9 4 10 5 What is ejaculation? 1 Bladder 2 Vas deferens Ejaculation is the release of semen from the penis 3 Urethra at orgasm (sexual climax). When a man is sexually 1 stimulated, the brain sends signals to the genital 6 4 Penis area through nerves in the spinal cord to make the 5 Scrotum 7 12 pelvic muscles contract. 2 8 6 Seminal vesicle 11 7 Rectum At orgasm, waves of muscle contractions transport 3 the sperm, with a small amount of fluid, from the 8 Prostate gland testes through to the vas deferens. The seminal 9 9 Epididymis vesicles and prostate contribute extra fluid to 4 10 Testicle protect the sperm. 10 11 Cowper’s gland 5 This mixture of sperm and fluid (semen) travels 12 Ejaculatory duct along the urethra to the tip of the penis where it is ejaculated (released). What are ejaculation problems? More details about premature ejaculation can be found in a separate1 Bladder Andrology Australia fact Men can experience different kinds of ejaculation sheet. 2 Vas deferens problems, including: 3 Urethra The other ejaculation4 Penis problems are less common • premature ejaculation than premature ejaculation5 Scrotum but can also cause distress for the man and his partner. • retrograde ejaculation 6 Seminal vesicle 7 Rectum • delayed ejaculation (or no ejaculation) What causes ejaculation problems? 8 Prostate gland • painful ejaculation. Ejaculation problems9 Epididymis can have a variety of 10 Testicle How common are ejaculation causes, both physical and psychological. Physical causes include11 Cowper’s some gland illnesses such problems? as diabetes, some 12typesEjaculatory of surgery duct or trauma, some types of inflammation or infection, certain Premature ejaculation is the most common male medicines, and chemical imbalances in the brain sexual problem and affects men of all ages.
    [Show full text]
  • Sacrohysteropexy for Uterine Prolapse (Womb Prolapse)
    Sacrohysteropexy for Uterine Prolapse (Womb Prolapse) Patient Information Leaflet About this leaflet You should use the information provided in this leaflet as a guide. The way each gynaecologist does this procedure may vary slightly as will care in the hospital after your procedure and the advice given to you when you get home. You should ask your gynaecologist about any concerns that you may have. You should take your time to read this leaflet. A page is provided at the end of the leaflet for you to write down any questions you may have. It is your right to know about your planned operation or procedure, why it has been recommended, what the alternatives are and what the risks and benefits are. These should be covered in this leaflet. You may also want to ask about your gynaecologist’s experience and results of treating your condition. Benefits and risks There are not many studies about the success and the risks of most of the procedures carried out to treat prolapse and incontinence, so it is often difficult to state them clearly. In this leaflet, we may refer to risks as common, rare and so on, or we may give an approximate level of risk. You can find more information about risk in a leaflet ‘Understanding how risk is discussed in healthcare’ published by the Royal College of Obstetricians and Gynaecologists. https://www.rcog.org.uk/globalassets/documents/patients/patient-information-leaflets/pi- understanding-risk.pdf The following table is taken from that leaflet British Society of Urogynaecology (BSUG) database To understand the success and risks of surgery for prolapse and incontinence the British Society of Urogynaecology has set up a national database.
    [Show full text]
  • Male Anorgasmia: from “No” to “Go!”
    Male Anorgasmia: From “No” to “Go!” Alexander W. Pastuszak, MD, PhD Assistant Professor Center for Reproductive Medicine Division of Male Reproductive Medicine and Surgery Scott Department of Urology Baylor College of Medicine Disclosures • Endo – speaker, consultant, advisor • Boston Scientific / AMS – consultant • Woven Health – founder, CMO Objectives • Understand what delayed ejaculation (DE) and anorgasmia are • Review the anatomy and physiology relevant to these conditions • Review what is known about the causes of DE and anorgasmia • Discuss management of DE and anorgasmia Definitions Delayed Ejaculation (DE) / Anorgasmia • The persistent or recurrent delay, difficulty, or absence of orgasm after sufficient sexual stimulation that causes personal distress Intravaginal Ejaculatory Latency Time (IELT) • Normal (median) à 5.4 minutes (0.55-44.1 minutes) • DE à mean IELT + 2 SD = 25 minutes • Incidence à 2-11% • Depends in part on definition used J Sex Med. 2005; 2: 492. Int J Impot Res. 2012; 24: 131. Ejaculation • Separate event from erection! • Thus, can occur in the ABSENCE of erection! Periurethral muscle Sensory input - glans (S2-4) contraction Emission Vas deferens contraction Sympathetic input (T12-L1) SV, prostate contraction Bladder neck contraction Expulsion Bulbocavernosus / Somatic input (S1-3) spongiosus contraction Projectile ejaculation J Sex Med. 2011; 8 (Suppl 4): 310. Neurochemistry Sexual Response Areas of the Brain • Pons • Nucleus paragigantocellularis Neurochemicals • Norepinephrine, serotonin: • Inhibit libido,
    [Show full text]